15th Sep 2010 15:16
Consort Medical plc (the 'Company')
Results of 2010 Annual General Meeting
The Annual General Meeting ('AGM') of the Company was held at 2pm on Wednesday 15 September 2010 at the Company's Registered Office, Breakspear Park, Breakspear Way, Hemel Hempstead, Hertfordshire HP2 4TZ.
All of the resolutions put to the meeting were duly passed on a show of hands. A summary of the forms of proxy for each resolution, received up to 48 hours before the time of the AGM, is set out below.
|
Resolution |
FOR* |
% of Votes |
AGAINST |
% of Votes |
WITHHELD |
|
|
1. |
To receive Annual Report and Accounts |
20,353,964 |
99.99 |
800 |
0.01 |
500,717 |
|
2. |
To approve the directors' remuneration report |
19,943,410 |
99.83 |
34,708 |
0.17 |
877,362 |
|
3. |
To declare a final dividend of 12.1 p per ordinary share |
20,354,764 |
100 |
0 |
0 |
500,717 |
|
4. |
To re-elect Jon Glenn as a director |
20,339,485 |
99.92 |
15,279 |
0.08 |
500,717 |
|
5. |
To re-elect Chris Banks as a director |
20,329,364 |
99.88 |
25,400 |
0.12 |
500,717 |
|
6. |
To reappoint PricewaterhouseCoopers LLP as auditors |
20,330,220 |
99.94 |
11,512 |
0.06 |
513,749 |
|
7. |
To authorise the directors to allot shares |
19,984,375 |
99.87 |
25,197 |
0.13 |
845,909 |
|
8. |
To authorise the directors to allot equity securities for cash |
15,798,143 |
77.63 |
4,551,716 |
22.37 |
505,622 |
|
9. |
To authorise the directors to make market purchases of the Company's shares |
20,341,001 |
99.93 |
13,650 |
0.07 |
500,830 |
|
10. |
To approve the calling of a general meeting on not less than 14 days' notice |
15,685,208 |
77.07 |
4,666,556 |
22.93 |
503,717 |
|
11. |
To approve and adopt the Consort Medical plc Company Share Option Plan 2010 |
20,308,243 |
99.84 |
33,158 |
0.16 |
514,080 |
* Where shareholders have appointed the Chairman of the AGM as their proxy with discretion as to voting, these votes have been cast in favour of all resolutions.
Abstentions are not votes and are not included in the % calculations
The full text of the resolutions can be found in the Notice of AGM on the Company's website (www.consortmendical.com) .
The Company confirms that a copy of all the special business resolutions passed at the AGM has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do"
For further information, please contact:
|
Consort Medical plc |
|
|
Jonathan Glenn, Chief Executive |
Tel: +44 (0) 1442 867920 |
|
Toby Woolrych, Group Finance Director |
Tel: +44 (0) 1442 867920 |
|
Brunswick |
|
|
Jon Coles/Justine McIlroy |
Tel: +44 (0) 20 7404 5959 |
Consort Medical plc is a leader in medical devices for inhaled drug delivery, self-injection and anaesthesia. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals.
Consort Medical develops and manufactures metered dose inhaler valves, actuators, compliance aids, dry powder devices autoinjectors, disposable facemasks, breathing circuits and laryngeal tubes. The Group has facilities in King's Lynn, Sheffield, Nelson and Hemel Hempstead in the UK, and Indianapolis, Indiana and Kent, Ohio in the US. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).
Related Shares:
CSRT.L